CN106562921B - A liquid oral composition containing Chinese medicinal active substances and tea tree essential oil - Google Patents
A liquid oral composition containing Chinese medicinal active substances and tea tree essential oil Download PDFInfo
- Publication number
- CN106562921B CN106562921B CN201610943361.9A CN201610943361A CN106562921B CN 106562921 B CN106562921 B CN 106562921B CN 201610943361 A CN201610943361 A CN 201610943361A CN 106562921 B CN106562921 B CN 106562921B
- Authority
- CN
- China
- Prior art keywords
- extract
- oil
- tea tree
- calcium chloride
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000009024 Ceanothus sanguineus Nutrition 0.000 title claims abstract description 84
- 240000003553 Leptospermum scoparium Species 0.000 title claims abstract description 84
- 235000015459 Lycium barbarum Nutrition 0.000 title claims abstract description 84
- 239000000341 volatile oil Substances 0.000 title claims abstract description 65
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 239000007788 liquid Substances 0.000 title claims abstract description 55
- 239000013543 active substance Substances 0.000 title claims abstract description 38
- 239000000284 extract Substances 0.000 claims abstract description 190
- 239000003814 drug Substances 0.000 claims abstract description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- 229940094952 green tea extract Drugs 0.000 claims abstract description 19
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 19
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 17
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940041616 menthol Drugs 0.000 claims abstract description 17
- -1 pH regulators Substances 0.000 claims abstract description 16
- 239000003755 preservative agent Substances 0.000 claims abstract description 12
- 239000000654 additive Substances 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims abstract description 6
- 239000000080 wetting agent Substances 0.000 claims abstract description 6
- 239000008394 flocculating agent Substances 0.000 claims abstract description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 87
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical group [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 64
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 56
- 235000019501 Lemon oil Nutrition 0.000 claims description 28
- 244000047670 Viola x wittrockiana Species 0.000 claims description 28
- 235000004031 Viola x wittrockiana Nutrition 0.000 claims description 28
- 239000010501 lemon oil Substances 0.000 claims description 28
- 235000001510 limonene Nutrition 0.000 claims description 28
- 229940087305 limonene Drugs 0.000 claims description 28
- 239000001509 sodium citrate Substances 0.000 claims description 27
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 27
- 238000002360 preparation method Methods 0.000 claims description 26
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 23
- 235000005747 Carum carvi Nutrition 0.000 claims description 23
- 240000000467 Carum carvi Species 0.000 claims description 23
- 244000228451 Stevia rebaudiana Species 0.000 claims description 22
- 239000001110 calcium chloride Substances 0.000 claims description 21
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 21
- 235000015763 Artemisia ludoviciana Nutrition 0.000 claims description 20
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 18
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 claims description 17
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 17
- 235000003805 Musa ABB Group Nutrition 0.000 claims description 17
- 235000015266 Plantago major Nutrition 0.000 claims description 17
- 238000001914 filtration Methods 0.000 claims description 17
- 229940105902 mint extract Drugs 0.000 claims description 17
- 241000241413 Propolis Species 0.000 claims description 16
- 229940069949 propolis Drugs 0.000 claims description 16
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 15
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 15
- 239000000811 xylitol Substances 0.000 claims description 15
- 235000010447 xylitol Nutrition 0.000 claims description 15
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 15
- 229960002675 xylitol Drugs 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 14
- 229920001661 Chitosan Polymers 0.000 claims description 13
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 13
- 229940059463 sesame seed extract Drugs 0.000 claims description 13
- 235000009508 confectionery Nutrition 0.000 claims description 12
- 239000003921 oil Substances 0.000 claims description 12
- 235000019198 oils Nutrition 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 230000001954 sterilising effect Effects 0.000 claims description 11
- 238000004659 sterilization and disinfection Methods 0.000 claims description 11
- 239000000686 essence Substances 0.000 claims description 10
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims description 9
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 8
- 238000007599 discharging Methods 0.000 claims description 8
- 230000002335 preservative effect Effects 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 claims description 6
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 6
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 6
- 229920000137 polyphosphoric acid Polymers 0.000 claims description 6
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 6
- BXOCHUWSGYYSFW-HVWOQQCMSA-N spilanthol Chemical compound C\C=C\C=C/CC\C=C\C(=O)NCC(C)C BXOCHUWSGYYSFW-HVWOQQCMSA-N 0.000 claims description 6
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 6
- 240000002943 Elettaria cardamomum Species 0.000 claims description 4
- 235000011203 Origanum Nutrition 0.000 claims description 4
- 240000000783 Origanum majorana Species 0.000 claims description 4
- 235000005300 cardamomo Nutrition 0.000 claims description 4
- 239000010634 clove oil Substances 0.000 claims description 4
- 239000010642 eucalyptus oil Substances 0.000 claims description 4
- 229940044949 eucalyptus oil Drugs 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims description 4
- 239000001683 mentha spicata herb oil Substances 0.000 claims description 4
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 claims description 4
- 239000010668 rosemary oil Substances 0.000 claims description 4
- 229940058206 rosemary oil Drugs 0.000 claims description 4
- 239000010670 sage oil Substances 0.000 claims description 4
- 235000019721 spearmint oil Nutrition 0.000 claims description 4
- 239000010678 thyme oil Substances 0.000 claims description 4
- 239000009637 wintergreen oil Substances 0.000 claims description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 3
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 claims description 3
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims description 3
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 claims description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 3
- 239000005973 Carvone Substances 0.000 claims description 3
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 3
- 241000723346 Cinnamomum camphora Species 0.000 claims description 3
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 claims description 3
- 239000005770 Eugenol Substances 0.000 claims description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 claims description 3
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 3
- 239000005844 Thymol Substances 0.000 claims description 3
- BXOCHUWSGYYSFW-UHFFFAOYSA-N all-trans spilanthol Natural products CC=CC=CCCC=CC(=O)NCC(C)C BXOCHUWSGYYSFW-UHFFFAOYSA-N 0.000 claims description 3
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 3
- 229940116229 borneol Drugs 0.000 claims description 3
- 229940067596 butylparaben Drugs 0.000 claims description 3
- 229930008380 camphor Natural products 0.000 claims description 3
- 229960000846 camphor Drugs 0.000 claims description 3
- 229940043350 citral Drugs 0.000 claims description 3
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims description 3
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 3
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 229940093476 ethylene glycol Drugs 0.000 claims description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 3
- 229960002217 eugenol Drugs 0.000 claims description 3
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 claims description 3
- 235000019717 geranium oil Nutrition 0.000 claims description 3
- 239000010648 geranium oil Substances 0.000 claims description 3
- 239000000832 lactitol Substances 0.000 claims description 3
- 235000010448 lactitol Nutrition 0.000 claims description 3
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 3
- 229960003451 lactitol Drugs 0.000 claims description 3
- 229930007744 linalool Natural products 0.000 claims description 3
- 239000000845 maltitol Substances 0.000 claims description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 3
- 235000010449 maltitol Nutrition 0.000 claims description 3
- 229940035436 maltitol Drugs 0.000 claims description 3
- 229930007503 menthone Natural products 0.000 claims description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 229960001047 methyl salicylate Drugs 0.000 claims description 3
- 229960002216 methylparaben Drugs 0.000 claims description 3
- 239000004302 potassium sorbate Substances 0.000 claims description 3
- 235000010241 potassium sorbate Nutrition 0.000 claims description 3
- 229940069338 potassium sorbate Drugs 0.000 claims description 3
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 3
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 229960003415 propylparaben Drugs 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 229960003885 sodium benzoate Drugs 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 229960002920 sorbitol Drugs 0.000 claims description 3
- 235000010356 sorbitol Nutrition 0.000 claims description 3
- 229960000790 thymol Drugs 0.000 claims description 3
- 241000205585 Aquilegia canadensis Species 0.000 claims 1
- 241000608847 Gnaphalium Species 0.000 claims 1
- 240000005561 Musa balbisiana Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 229960002449 glycine Drugs 0.000 claims 1
- 239000003205 fragrance Substances 0.000 abstract description 5
- 230000000996 additive effect Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 72
- 241001570521 Lonicera periclymenum Species 0.000 description 29
- 238000000605 extraction Methods 0.000 description 24
- 244000267790 Artemisia ludoviciana Species 0.000 description 19
- 244000269722 Thea sinensis Species 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 241001127637 Plantago Species 0.000 description 17
- 235000013616 tea Nutrition 0.000 description 15
- 238000010438 heat treatment Methods 0.000 description 13
- 210000000214 mouth Anatomy 0.000 description 13
- 239000002324 mouth wash Substances 0.000 description 13
- 229940051866 mouthwash Drugs 0.000 description 12
- 238000002791 soaking Methods 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 238000005303 weighing Methods 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 230000010415 tropism Effects 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 235000014220 Rhus chinensis Nutrition 0.000 description 7
- 240000003152 Rhus chinensis Species 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 230000002688 persistence Effects 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 235000017617 Lonicera japonica Nutrition 0.000 description 5
- 244000167230 Lonicera japonica Species 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 4
- 240000006891 Artemisia vulgaris Species 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 230000035597 cooling sensation Effects 0.000 description 4
- 230000003467 diminishing effect Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000009569 green tea Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 201000009240 nasopharyngitis Diseases 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 3
- 235000003097 Artemisia absinthium Nutrition 0.000 description 3
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 244000150738 Sesamum radiatum Species 0.000 description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 3
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000001138 artemisia absinthium Substances 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229940116411 terpineol Drugs 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- ULDHMXUKGWMISQ-VIFPVBQESA-N (+)-carvone Chemical compound CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 description 2
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 2
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 240000000011 Artemisia annua Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000743774 Brachypodium Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 235000005976 Citrus sinensis Nutrition 0.000 description 2
- 240000002319 Citrus sinensis Species 0.000 description 2
- 229920000832 Cutin Polymers 0.000 description 2
- 229930186291 Dulcoside Natural products 0.000 description 2
- CANAPGLEBDTCAF-QHSHOEHESA-N Dulcoside A Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@]34CC[C@H]5[C@]6(C)CCC[C@](C)([C@H]6CC[C@@]5(CC3=C)C4)C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H](O)[C@H]1O CANAPGLEBDTCAF-QHSHOEHESA-N 0.000 description 2
- CANAPGLEBDTCAF-NTIPNFSCSA-N Dulcoside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@]23C(C[C@]4(C2)[C@H]([C@@]2(C)[C@@H]([C@](CCC2)(C)C(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)CC4)CC3)=C)O[C@H](CO)[C@@H](O)[C@@H]1O CANAPGLEBDTCAF-NTIPNFSCSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010030973 Oral discomfort Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 240000008313 Pseudognaphalium affine Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000405217 Viola <butterfly> Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- 229940106705 chlorophyll Drugs 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- DTPRTOXMYKYSIJ-UHFFFAOYSA-N eupatorin Natural products C1=C(O)C(OC)=CC=C1C1=CC(=O)C2=CC(OC)=C(OC)C=C2O1 DTPRTOXMYKYSIJ-UHFFFAOYSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 235000020737 peppermint extract Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000009777 vacuum freeze-drying Methods 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- FAMJUFMHYAFYNU-JTQLQIEISA-N (4r)-1-methyl-4-propan-2-ylcyclohexene Chemical compound CC(C)[C@@H]1CCC(C)=CC1 FAMJUFMHYAFYNU-JTQLQIEISA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical group Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010060954 Abdominal Hernia Diseases 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000242759 Actiniaria Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241001151957 Aphis aurantii Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 235000001405 Artemisia annua Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 235000004355 Artemisia lactiflora Nutrition 0.000 description 1
- 240000004950 Artemisia lactiflora Species 0.000 description 1
- 235000017519 Artemisia princeps Nutrition 0.000 description 1
- 244000065027 Artemisia princeps Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 241001113925 Buddleja Species 0.000 description 1
- YYEQHIXJBSSBJU-UHFFFAOYSA-L C(C=C)(=O)O.[Cl-].[Ca+2].[Cl-] Chemical compound C(C=C)(=O)O.[Cl-].[Ca+2].[Cl-] YYEQHIXJBSSBJU-UHFFFAOYSA-L 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 244000166675 Cymbopogon nardus Species 0.000 description 1
- 235000018791 Cymbopogon nardus Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004267 EU approved acidity regulator Substances 0.000 description 1
- 206010014198 Eczema infantile Diseases 0.000 description 1
- 208000003468 Ehrlich Tumor Carcinoma Diseases 0.000 description 1
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 206010048461 Genital infection Diseases 0.000 description 1
- 241000735332 Gerbera Species 0.000 description 1
- 241000146384 Glaux Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000756137 Hemerocallis Species 0.000 description 1
- 235000017209 Hemerocallis flava Nutrition 0.000 description 1
- 244000172419 Hemerocallis flava Species 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000008017 Hypohidrosis Diseases 0.000 description 1
- 241000132446 Inula Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241001466453 Laminaria Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 244000307609 Mangifera caesia Species 0.000 description 1
- 235000011378 Matthiola incana Nutrition 0.000 description 1
- 244000088413 Matthiola incana Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001473283 Mikania Species 0.000 description 1
- 241000512861 Myzus certus Species 0.000 description 1
- 235000010679 Nepeta cataria Nutrition 0.000 description 1
- 240000009215 Nepeta cataria Species 0.000 description 1
- 235000011755 Nepeta hederacea Nutrition 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 241000120647 Osbeckia Species 0.000 description 1
- 241001499733 Plantago asiatica Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000218206 Ranunculus Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 241000207961 Sesamum Species 0.000 description 1
- 235000009367 Sesamum alatum Nutrition 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 244000111146 Sonchus arvensis Species 0.000 description 1
- 235000008132 Sonchus arvensis ssp. uliginosus Nutrition 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- OMHUCGDTACNQEX-OSHKXICASA-N Steviolbioside Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OMHUCGDTACNQEX-OSHKXICASA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 244000152045 Themeda triandra Species 0.000 description 1
- 241000133430 Tinospora Species 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 241001278775 Veronicastrum Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 241001106476 Violaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 206010002512 anhidrosis Diseases 0.000 description 1
- 230000037001 anhydrosis Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- IWTJDVBNIUPPPB-UHFFFAOYSA-N beta-Sitosterol palmitate Chemical compound C12CCC3(C)C(C(C)CCC(CC)C(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCC)C2 IWTJDVBNIUPPPB-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229940082501 camellia sinensis root extract Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- JLPRGBMUVNVSKP-AHUXISJXSA-M chembl2368336 Chemical compound [Na+].O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C([O-])=O)[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O JLPRGBMUVNVSKP-AHUXISJXSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- ZDKZHVNKFOXMND-UHFFFAOYSA-N epinepetalactone Chemical compound O=C1OC=C(C)C2C1C(C)CC2 ZDKZHVNKFOXMND-UHFFFAOYSA-N 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- KLAOKWJLUQKWIF-UHFFFAOYSA-N eupatorin Chemical compound C1=C(O)C(OC)=CC=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C=C2O1 KLAOKWJLUQKWIF-UHFFFAOYSA-N 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000009874 shenqi Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- OHLDETMXEXJUDZ-UHFFFAOYSA-N stigmasteryl palmitate Natural products C12CCC3(C)C(C(C)C=CC(CC)C(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCC)C2 OHLDETMXEXJUDZ-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a liquid oral composition containing traditional Chinese medicine active substances and tea tree essential oil, which comprises the following components in parts by weight: 1.0-10 parts of traditional Chinese medicine extract, 0.1-6 parts of additive, 0.001-0.005 part of menthol, 0.001-0.006 part of tea tree essential oil and 90-100 parts of water; wherein the Chinese medicinal extract comprises green tea extract, herba Gnaphalii affinis extract, herba plantaginis extract, herba Lamii Barbati extract, tea tree root extract, Galla chinensis, flos Lonicerae and pericarpium Citri Junoris mixed extract, and violet extract; the additives include wetting agents, pH regulators, preservatives, fragrances and flocculants.
Description
Technical Field
The invention relates to the technical field of oral care products, and particularly provides a liquid oral composition containing traditional Chinese medicine active substances and tea tree essential oil.
Background
The mouth wash in the liquid oral composition is an oral care product for cleaning and health care in daily life of people, and is mainly used for keeping the oral cavity and teeth clean, promoting breath freshening, nursing gingiva, maintaining good microenvironment of the oral cavity and the like.
At present, the traditional Chinese medicine mouth wash which is commonly used in the market has a plurality of types, and the traditional Chinese medicine mouth wash is mainly formed by adding corresponding traditional Chinese medicine components into a mouth wash water body matrix which forms the mouth wash, and is used for inhibiting harmful bacteria in oral cavity, diminishing inflammation, easing pain, preventing body desensitization, preventing decayed teeth, and preventing and treating periodontal diseases such as gingivitis, periodontitis, tooth bleeding and the like.
To impart a refreshing feeling in use, ethanol is usually mixed in mouthwash. However, ethanol is accompanied by irritation in the oral cavity, easily causes white lesions in the oral mucosa, affects the alcohol test concentration, and is not suitable for oral disinfection after an outbreak of food.
In addition, in the case of non-alcoholic mouth washes, the emulsion is easily disintegrated, which affects the appearance stability of the mouth wash and the usability of the mouth wash.
The tea tree essential oil has the effects of sterilizing, diminishing inflammation, removing oral odor, preventing tooth decay and keeping fresh breath.
Therefore, in view of the above problems, there is a need for a non-alcoholic tea tree essential oil-containing liquid oral composition which can clean the oral cavity and teeth, promote fresh breath, care gums, maintain a good microenvironment in the oral cavity, and has excellent appearance stability and usability.
Disclosure of Invention
The invention provides a liquid oral composition containing traditional Chinese medicine active substances and tea tree essential oil, which comprises the following components in parts by weight:
wherein the Chinese medicinal extract comprises green tea extract, herba Gnaphalii affinis extract, herba plantaginis extract, herba Lamii Barbati extract, tea tree root extract, Galla chinensis, flos Lonicerae and pericarpium Citri Junoris mixed extract, and violet extract; the additives include wetting agents, pH regulators, preservatives, fragrances and flocculants.
In one embodiment, the herbal extracts further comprise peppermint extract, stevia extract, pansy extract, caraway extract.
In one embodiment, the humectant comprises one or more of sorbitol, xylitol, maltitol, lactitol, ethylene glycol.
In one embodiment, the pH adjusting agent comprises one or more of phthalic acid, phosphoric acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid, carbonic acid, sodium dihydrogen phosphate, sodium monohydrogen phosphate, sodium citrate.
In one embodiment, the preservative comprises one or more of sodium benzoate, methyl paraben, ethyl paraben, propyl paraben, butyl paraben, and other parabens, glycine alkyl diamino ethyl ester hydrochloride, potassium sorbate, propolis.
In one embodiment, the essence comprises one or more of spearmint oil, eucalyptus oil, wintergreen oil, clove oil, thyme oil, sage oil, cardamom oil, rosemary oil, marjoram oil, lemon oil, nutmeg oil, lavender oil, geranium oil, L-carvone, 1, 8-cineole, methyl salicylate, eugenol, thymol, linalool, limonene, menthone, menthyl acetate, citral, camphor, borneol, pinene, spilanthol.
In one embodiment, the flocculant is modified calcium chloride, and the modified calcium chloride is acrylic acid coated calcium chloride and then grafted chitosan.
In one embodiment, the modified calcium chloride has a grafting ratio of 1 to 5%.
In one embodiment, the modified calcium chloride has a grafting ratio of 1 to 3%.
In another aspect of the present invention, there is provided a method for preparing a liquid oral composition containing a Chinese medicinal active substance and tea tree essential oil, comprising the steps of:
(1) adding the traditional Chinese medicine extract, menthol, tea tree essential oil and water according to the weight part, and stirring to dissolve the traditional Chinese medicine extract in the water;
(2) adding additives according to the weight parts, fully stirring, filtering, taking filtrate, and performing sterilization treatment to obtain the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil.
The above-described and other features, aspects, and advantages of the present application will become more apparent with reference to the following detailed description.
Detailed Description
The disclosure may be understood more readily by reference to the following detailed description of preferred embodiments of the invention and the examples included therein. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In case of conflict, the present specification, including definitions, will control.
The term "prepared from …" as used herein is synonymous with "comprising". The terms "comprises," "comprising," "includes," "including," "has," "having," "contains," "containing," or any other variation thereof, as used herein, are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus.
The conjunction "consisting of …" excludes any unspecified elements, steps or components. If used in a claim, the phrase is intended to claim as closed, meaning that it does not contain materials other than those described, except for the conventional impurities associated therewith. When the phrase "consisting of …" appears in a clause of the subject matter of the claims rather than immediately after the subject matter, it defines only the elements described in the clause; other elements are not excluded from the claims as a whole.
When an amount, volume fraction, or other value or parameter is expressed as a range, preferred range, or as a range of upper preferable values and lower preferable values, this is to be understood as specifically disclosing all ranges formed from any pair of any upper range limit or preferred value and any lower range limit or preferred value, regardless of whether ranges are separately disclosed. For example, when a range of "1 to 5" is disclosed, the described range should be interpreted to include the ranges "1 to 4", "1 to 3", "1 to 2 and 4 to 5", "1 to 3 and 5", and the like. When a range of values is described herein, unless otherwise stated, the range is intended to include the endpoints thereof and all integers and fractions within the range.
The singular forms "a", "an" and "the" include plural referents unless the context clearly dictates otherwise. "optional" or "any" means that the subsequently described event or events may or may not occur, and that the description includes instances where the event occurs and instances where it does not.
Approximating language, as used herein throughout the specification and claims, is intended to modify a quantity, such that the invention is not limited to the specific quantity, but includes portions that are literally received for modification without substantial change in the basic function to which the invention is related. Accordingly, the use of "about" to modify a numerical value means that the invention is not limited to the precise value. In some instances, the approximating language may correspond to the precision of an instrument for measuring the value. In the present description and claims, range limitations may be combined and/or interchanged, including all sub-ranges contained therein if not otherwise stated.
In addition, the indefinite articles "a" and "an" preceding an element or component of the invention are not intended to limit the number requirement (i.e., the number of occurrences) of the element or component. Thus, "a" or "an" should be read to include one or at least one, and the singular form of an element or component also includes the plural unless the stated number clearly indicates that the singular form is intended.
"blend" means a polymer formed by two or more polymers being mixed together by physical or chemical means.
The invention provides a liquid oral composition containing traditional Chinese medicine active substances and tea tree essential oil, which comprises the following components in parts by weight:
wherein the Chinese medicinal extract comprises green tea extract, herba Gnaphalii affinis extract, herba plantaginis extract, herba Lamii Barbati extract, tea tree root extract, Galla chinensis, flos Lonicerae and pericarpium Citri Junoris mixed extract, and violet extract; the additives include wetting agents, pH regulators, preservatives, fragrances and flocculants.
In one embodiment, the herbal extracts further comprise peppermint extract, stevia extract, pansy extract, caraway extract.
In one embodiment, the traditional Chinese medicine extract comprises, by weight, 1-2 parts of green tea extract, 0.1-1 part of affine cudweed extract, 0.1-1 part of plantain extract, 0.5-1.5 parts of sesameseed extract, 0.1-1.0 part of tea tree root extract, 0.5-3 parts of mixed extract of Chinese gall, honeysuckle and orange peel, 0.01-0.1 part of violet extract, 0.1-1.2 parts of mint extract, 0.05-1.0 part of sweet stevia extract, 0.003-0.2 part of trichrome extract and 0.005-0.3 part of caraway extract.
In one embodiment, the wetting agent is 1-5 parts, the pH regulator is 0.1-0.3 part, the preservative is 0.01-0.1 part, the essence is 0.001-0.1 part, and the flocculating agent is 0.01-0.15 part by weight.
Green tea
The green tea is prepared by fermenting, retains natural substances of fresh leaves, and contains more nutrients such as tea polyphenols, catechin, chlorophyll, caffeine, amino acids, vitamins, etc. The natural nutrient components in the green tea have special effects of preventing aging, cancer, resisting cancer, sterilizing, diminishing inflammation and the like. The green tea is prepared from tea shoots as raw materials by typical processes of de-enzyming, rolling, drying and the like.
Gnaphalium affine
Alias: daylily, cudweed herb, wormwood, veronicastrum herb, gerbera dioica [ Guangdong ], distiller's yeast velvet, white fungus, cudweed herb, citronella, herba et Gemma Agrimoniae, Artemisia annua, downy wormwood, rice koji, hirsute herb, cotton catnip, Mikania sinensis, Japanese milkwort herb, Japanese inula herb, herba inulae, rhizoma anemones Flagelliformis, sowthistle herb, Qingmingxiang, tophyllum odoratum, cotton cauliflower, spinach herb, cotton cocoons, Tinospora capillaris, cudweed herb, Japanese bluegrass herb, Japanese mugwort, tarragon, white mugwort, water yeast, chorionic villous grass, silk cotton grass, hiraute rocky wormwood herb, ternate buttercup herb, Chinese trumpet fern herb, catfoot herb, floret buddleja herb, hairy mugwort, yellow day lily, glutinous rice green, cotton herb, white mango and grass. The whole herb contains 5% of flavonoid glycoside, 0.05% of volatile oil, trace alkaloids and sterols, 0.58% of non-perfoliate, and vitamin B, carrot, chlorophyll, resin, fat, etc. Flower containing luteolin-4-beta-D-glucoside (luteline-4-beta-D-glucoside)
Nature, flavor and meridian tropism: sweet and neutral.
The functional indications are as follows: relieve cough and asthma, lower blood pressure, dispel wind-damp. Can be used for treating common cold with cough, bronchitis, asthma, hypertension, fava bean disease, rheumatism, lumbago, and skelalgia; it is used externally to treat traumatic injury and venomous snake bite.
Plantago asiatica
The whole plant contains plantaginide (Plantago sativa L), aucubin (Aucnbin), ursolic acid (Uralicacid), B-sitosterol, n-hentriacontane, B-sitosterol palmitate, stigmasterol palmitate, vitamin B, vitamin C, and plantaginide (plantaglusid) (which is composed of D-methyl galacturonate, D-galactose, L-arabinose, L-rhamnose, etc.). Protein, succinic acid, adenine, choline, catalpol, stearic acid, arachidic acid, linolenic acid, and linoleic acid.
The nature, taste and function: sweet and cold in nature, entering the hand-Taiyang meridians and yangming meridians. Inducing diuresis, clearing heat, improving eyesight, eliminating phlegm, and can be used for treating dysuria, stranguria with turbid urine, leukorrhagia, hematuria, jaundice, edema, dysentery with diarrhea, epistaxis, conjunctival congestion, swelling and pain, laryngalgia, cough, and skin ulcer.
All-grass of dwarf sessile wildweed
The wild sesame seed (Laium album) is a plant species of the genus Lamiaceae and genus Laminaria. The young leaves are edible, the flowers can be used as medicine, and the whole herb contains saponin, tannin, caffeic acid and various amino acids.
The nature, taste and function: sweet, bitter and cool. Enter liver, kidney and bladder meridians. Promoting blood circulation, removing blood stasis, relieving swelling and pain.
Root of tea tree
The fresh root contains saccharide such as stachyose, raffinose, sucrose, glucose, fructose, etc., and small amount of polyphenol compounds (flavanol, etc.).
The nature, taste and function: bitter; and (6) cooling. Entering the heart; the kidney channel. Strengthening heart and promoting urination; promoting blood circulation to regulate menstruation; clearing away heat and toxic material. Heart disease; edema; hepatitis; dysmenorrhea; sores and ulcers with pyogenic infections; aphtha; burn due to hot soup and fire; herpes zoster; psoriasis vulgaris.
Galla chinensis
The Galla chinensis angle is rhombic or oval, has irregular angular branches, and has a length of 3-8 cm and a diameter of 2-5 cm. The surface is yellow or light yellow brown, and the gray color is soft and smooth, and the short villus is more obvious. Hard and brittle, broken and hollow, with thin wall of about 0.1-0.2 cm, cutin, and most black and brown aphid corpses and gray powder excrement. The inner wall was light brown and smooth. And cutting off cutin. Slightly peculiar odor and astringent taste.
Medicine property: sour, astringent and cold. It enters lung, large intestine and kidney meridians.
The efficacy is as follows: astringe lung to reduce fire, relieve cough and stop sweating, check diarrhea with astringents, secure essence and check nocturnal emission, astringe to stop bleeding, astringe dampness and heal wound.
The main treatment is as follows: cough, hemoptysis, spontaneous perspiration, night sweat, chronic diarrhea, chronic dysentery, spermatorrhea, metrorrhagia, hematochezia, hemorrhoid, eczema, and toxic swelling.
Honeysuckle flower
Honeysuckle, also known as honeysuckle, honeysuckle flower, etc., has been known as a good medicine for clearing heat and removing toxicity since ancient times. It is sweet and cold in nature and fragrant, sweet and cold in nature and clearing heat without hurting stomach, and the fragrance is thorough and can eliminate pathogens. Honeysuckle can disperse wind-heat and clear blood toxin, and has obvious effect on various heat diseases such as fever, eruption, macula, sore and carbuncle due to heat toxin, sore throat and the like. According to the 2005 edition of the Chinese pharmacopoeia, Lonicera japonica is a dried bud or a flower with an initial bloom of Lonicera japonica (Lonicera japonica Thunb) belonging to the genus Lonicera of the family Caprifoliaceae.
The honeysuckle has broad-spectrum antibacterial effect and has stronger inhibition effect on pathogenic bacteria such as staphylococcus aureus, dysentery bacillus and the like; has obvious anti-inflammatory and antipyretic effects; the water and wine soaking solution of flos Lonicerae has obvious cytotoxic effect on sarcoma 180 and Ehrlich ascites tumor, and also has certain cholesterol lowering effect.
Nature, flavor and meridian tropism: sweet and cold in nature. It enters lung, heart and stomach meridians.
The efficacy application is as follows: clear heat and remove toxicity, disperse wind-heat. It can be used for treating carbuncle, furunculosis, red swelling, pain, wind-heat, warm disease, dysentery, summer heat, polydipsia, and sore throat.
Violet is a new type
Violet, latin literature name: (Matthiola incana (L.) R.Br.) Cruciferae, Viola genus biennial or perennial herbs. The whole plant is densely covered by offwhite branches with stems. The stem is upright, multi-branched, and slightly lignified at the base. The long round shape of the leaf blade is the shape of a reversed scalded needle or a spoon.
Violet has the effects of clearing heat and removing toxicity, whitening and removing freckles, moistening skin, removing wrinkles and freckles, removing peculiar smell in the oral cavity, enhancing gloss and preventing ultraviolet irradiation, has great help to respiratory tracts, has the effect of conditioning bronchitis, can moisten throat and solves the peculiar smell in the oral cavity caused by decayed teeth.
Mint
The mint, named as "Yindancao" is a labiate plant, i.e., other dry whole herbs of the same genus, mostly grows beside the mountain wetland, with roots and stems transversely growing underground. The whole plant is green and fragrant. The leaves are in pairs, the flowers are small and light purple, the lips are shaped, and dark purple brown small-grain fruits are formed after the flowers are bloomed.
The herba Menthae has special fragrance, pungent taste and cool feeling, and can be used in medicine for dispelling pathogenic wind, preventing corrosion, relieving inflammation, relieving pain, relieving itching, invigorating stomach, etc. The whole herb is pungent and cool. It enters lung and liver meridian, has effects of dispelling pathogenic wind heat, clearing and removing heat from throat, promoting eruption, removing toxic substance, dispersing stagnated liver qi, relieving qi stagnation and itching etc., is suitable for common cold with fever, headache, sore throat, anhidrosis, wind fire with red eyes, rubella, skin itch, hernia pain, dysentery and lymphoid tuberculosis etc., and has slight analgesic effect for external use, and is used for neuralgia etc.
Stevia rebaudiana (Bertoni) Hemsl
The leaf contains stevioside, steviolbioside, stevioside A, stevioside B, dulcoside A, dulcoside B, dulcoside C, D, E, dulcoside A, 6-O-acetyl eupatorin, eupatiol, and eupatorin.
Nature, flavor and meridian tropism: sweet and cold; it enters lung and stomach meridians.
The efficacy and the effect are as follows: promoting the production of body fluid to quench thirst; reducing blood pressure. Diabetes mainly; hypertension.
Orange peel
The pericarpium Citri Junoris is pericarp of Citrus sinensis of Rutaceae. The sweet orange evergreen small arbor is cultivated on hills, low mountain areas, along banks of rivers and lakes, and is cultivated in every part of the south of the Yangtze river in China, and the variety is large. In winter or in the beginning of spring, the peeled pericarp is dried in the sun or baked.
Nature, flavor and meridian tropism: warm in nature, sweet and bitter in taste and non-toxic; enter spleen and lung meridians.
The efficacy and the effect are as follows: regulate qi, resolve phlegm, invigorate spleen and remove stagnancy. It is used to treat common cold, cough, anorexia, abdominal distention, borborygmus, diarrhea, and acute mastitis.
Viola tricolor
Viola tricolor L is an annual or short-lived perennial herb of Viola of the family Violaceae. The stem and leaf contain pansy glycoside; the flower contains rutin, volatile oil, saponin, and vitamin A, C. The pansy can kill bacteria and treat acne and allergy on skin. The Shenqi pox-removing efficacy of pansy is carried in detail in the shengdian of traditional Chinese medicine (compendium of materia Medica): pansy, mild in nature and superficial temperature, fragrant in flavor, can be used to guide herbs to go upward to the surface to remove sores and scars and relieve swelling of sores and ulcers. The pansy whole plant can be used as a medicine, and stem leaves contain pansy, so that the pansy whole plant is mainly used for treating diseases such as cough and the like.
Nature, flavor and meridian tropism: cold and bitter; meridian tropism and lung meridian tropism.
The efficacy and the effect are as follows: clearing away heat and toxic materials; relieving cough. Treating pyocutaneous disease with pyogenic infections; infantile eczema; scrofula of children; and (5) cough.
Carum carvi
Carum carvi is the fruit of the plant Artemisia annua of Umbelliferae. The fruit contains volatile oil 3.5-7% of caraway oil, and the oil contains main components of d-carvone 50-60% and d-limonene.
Nature, flavor and meridian tropism: warm in nature, sweet and pungent in flavor; enter kidney and stomach meridians.
The efficacy and the effect are as follows: fragrant, invigorating stomach, expelling wind and regulating qi. It is indicated for stomach ache, abdominal pain and hernia of small intestine.
The extraction method of the green tea extract comprises the following steps:
tea polysaccharide: 20g of the pulverized tea sample is taken, and the mixture is mixed with distilled water preheated to 55 ℃ in a ratio of 1: extracting at a ratio of 20(w/v) in a water bath at 55 deg.C for 2.5h under stirring, filtering, centrifuging at 4000r/min for 15min, collecting supernatant, concentrating, precipitating with 3 times volume of 95% ethanol, centrifuging to obtain tea polysaccharide precipitate, and freeze drying to obtain tea polysaccharide.
Tea polyphenol: 20g of the pulverized tea sample is taken, and the mixture is mixed with distilled water preheated to 55 ℃ in a ratio of 1: extracting with 20(w/V) water bath at 55 deg.C under stirring for 2.5h, filtering, centrifuging at 400Or/min for 15min, collecting supernatant, concentrating, and extracting with A13+Precipitating tea polyphenols in pH5.3-5.7 environment, dissolving tea polyphenols-aluminum precipitate, extracting with ethyl acetate for 3 times, and vacuum freeze drying to obtain tea polyphenols (I); and taking a proper amount of supernatant, concentrating, extracting for 3 times by using ethyl acetate with the same volume, and carrying out vacuum freeze drying to obtain the tea polyphenol (II).
The extraction method of the affine cudweed extract comprises the following steps:
weighing 20.0g of affine cudweed, drying, crushing, adding ethanol with the mass concentration of 70% -80%, soaking for 2-3 h, extracting for 2-3 times by microwave heating, filtering, and concentrating the filtrate under reduced pressure until no ethanol exists, thus obtaining the affine cudweed.
The extraction method of the plantain herb extract comprises the following steps:
weighing 20.0g of plantain, drying, crushing, adding 80-90% ethanol by mass concentration, soaking for 2-3 h, extracting for 2-3 times by microwave heating, filtering, and concentrating the filtrate under reduced pressure until no ethanol exists, thus obtaining the plantain extract.
The extraction method of the sesameia brachypodium extract comprises the following steps:
cleaning and chopping the short-stalk wild sesame flower, adding a citric acid aqueous solution with the mass concentration of 3-5 g/L, soaking for 2-3 h, extracting for 2-3 times by microwave heating, filtering, and drying the filtrate under reduced pressure to obtain the wild sesame flower.
The extraction method of the tea tree root extract comprises the following steps:
weighing 20.0g of tea tree root, cleaning, drying, crushing, adding 75-85% ethanol by mass concentration, soaking for 2-3 h, extracting for 2-3 times by microwave heating, filtering, and concentrating the filtrate under reduced pressure until no ethanol exists, thus obtaining the tea tree root extract.
The extraction method of the violet extract comprises the following steps:
weighing 20.0g of dried violet, crushing, adding into hot water at 100 ℃, soaking for 1h, then adding ethanol with the concentration of 80-85%, heating and extracting for 1-3 times by using microwave with the microwave power of 80-100W, filtering, and concentrating the filtrate under reduced pressure until no ethanol exists, thus obtaining the violet-tea beverage.
The extraction method of the mint extract comprises the following steps:
pulverizing herba Menthae into coarse powder, and placing in supercritical CO2An extraction device, under the conditions of 6MPa of analytic pressure, 35 ℃ of analytic temperature, 3.0h of extraction time, 45 ℃ of extraction temperature, 35MPa of extraction pressure and CO2The flow rate is 40kg/h to obtain the mint extract.
The extraction method of the stevia rebaudiana extract comprises the following steps:
pulverizing sweet stevia into coarse powder, and placing in supercritical CO2An extraction device, under the conditions of 6MPa of analytic pressure, 40 ℃ of analytic temperature, 3.0h of extraction time, 55 ℃ of extraction temperature, 40MPa of extraction pressure and CO2The flow rate is 50kg/h to obtain stevia extract.
The extraction method of the mixed extract of the Chinese gall, the honeysuckle and the orange peel comprises the following steps:
mixing Galla chinensis, flos Lonicerae and pericarpium Citri Junoris at a weight ratio, blasting and pulverizing to 100-mesh 200 meshes, mixing with 0.1 weight part of 2-mercaptobenzothiazole, extracting with ethanol as solvent, refluxing for 2h, filtering while hot, and concentrating until no ethanol is present.
In one embodiment, the weight ratio of the gallnut to the honeysuckle and the orange peel is 1: 0.3: 0.2.
the extraction method of the pansy extract comprises the following steps:
weighing 20.0g of dried pansy, crushing, adding into hot water of 90 ℃, soaking for 2h, then adding 75-85% ethanol, heating and extracting for 1-3 times by using microwave with the microwave power of 80-100W, filtering, and concentrating the filtrate under reduced pressure until no ethanol exists, thus obtaining the pansy.
The extraction method of the Carum carvi extract comprises the following steps:
weighing 20.0g of dried caraway, crushing, adding into hot water of 100 ℃, soaking for 2h, then adding ethanol with the concentration of 95%, heating and extracting for 1-3 times by using microwave with the microwave power of 80-100W, filtering, and concentrating the filtrate under reduced pressure until no ethanol exists, thus obtaining the caraway.
In one embodiment, the humectant comprises one or more of sorbitol, xylitol, maltitol, lactitol, ethylene glycol.
Tea tree essential oil
Tea tree essential oil is native to Australia and is an extract of tea tree. Has antibacterial, antiinflammatory, pore astringing, common cold, cough, rhinitis, asthma treating, dysmenorrhea improving, menoxenia and genital infection relieving effects. It is suitable for oily and acne skin, and can be used for treating suppurative wound, burn, sunburn, tinea pedis, and dandruff. Refreshing brain, restoring vitality and resisting depression.
The most important chemical components are p-menthene (terpinene), terpineol (pinene), limonene (limone), cineol (cineole), terpineol (terpineol) and anisic acid (cumene).
The extraction method takes the leaves and the tender tips as raw materials, adopts a steam distillation method for extraction, and has the oil yield of 1.8 percent.
pH regulator
A pH adjuster, also called a pH adjuster, an acidity adjuster or a pH controller, etc., is used as a food additive for adjusting or maintaining the pH (acid or alkali). The acidity regulator may be an organic or inorganic acid, a base, a neutralizing agent or a buffer.
Acidity regulators have many functional properties that enhance the quality of food products, such as altering and maintaining the acidity and improving the flavor of food products; improving antioxidant effect, and preventing food spoilage; complexing with heavy metal ions, the product has the effects of preventing oxidation or browning reaction, stabilizing color, reducing turbidity, enhancing gelation property, etc.
In one embodiment, the pH adjusting agent comprises one or more of phthalic acid, phosphoric acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid, carbonic acid, sodium dihydrogen phosphate, sodium monohydrogen phosphate, sodium citrate; preferably, the pH regulator is citric acid or sodium citrate.
In one embodiment, the weight ratio of the citric acid to the sodium citrate is 1: 0.8.
preservative
The preservative is a food additive which is a natural or synthetic chemical component and is used for keeping the original quality and the nutritional value of food. The preservative mainly acts as an agent for inhibiting the growth and reproduction of microorganisms, so as to prolong the storage time of food and inhibit the putrefaction of substances. The food preservative can inhibit the activity of microorganisms and prevent the food from being rotten, thereby prolonging the shelf life of the food.
In one embodiment, the preservative comprises one or more of sodium benzoate, methyl paraben, ethyl paraben, propyl paraben, butyl paraben and other parabens, glycine alkyl diamino ethyl ester hydrochloride, potassium sorbate, propolis; preferably, the preservative is propolis.
Essence
The essence is a concentrated aromatic oil which is synthesized by people and imitates the smell of fruits and natural spices.
In one embodiment, the essence comprises one or more of spearmint oil, eucalyptus oil, wintergreen oil, clove oil, thyme oil, sage oil, cardamom oil, rosemary oil, marjoram oil, lemon oil, nutmeg oil, lavender oil, geranium oil, L-carvone, 1, 8-cineole, methyl salicylate, eugenol, thymol, linalool, limonene, menthone, menthyl acetate, citral, camphor, borneol, pinene, spilanthol; preferably, the essence comprises one or more of spearmint oil, eucalyptus oil, wintergreen oil, clove oil, thyme oil, sage oil, cardamom oil, rosemary oil, marjoram oil, lemon oil, nutmeg oil, lavender oil, osbeckia oil, limonene; more preferably, the essence is one or more of lemon oil and limonene.
In one embodiment, the flocculant is modified calcium chloride, and the modified calcium chloride is acrylic acid coated calcium chloride and then grafted chitosan.
In one embodiment, the modified calcium chloride has a grafting ratio of 1 to 5%.
In one embodiment, the modified calcium chloride has a grafting ratio of 1 to 3%.
In one embodiment, the modified calcium chloride is prepared as follows:
(1) adding calcium chloride into a high-speed mixer with a charging basket at 50 ℃, adding acrylic acid according to the weight ratio, stirring for 0.5-2 h, discharging, raising the temperature of the charging basket of the high-speed mixer to 120 ℃, pouring the materials into the high-speed mixer, stirring at high speed for 0.5-1 h, and discharging to obtain acrylic acid coated calcium chloride; the weight ratio of the acrylic acid to the calcium chloride is 1: (10-20);
(2) fully dissolving chitosan in water to prepare an aqueous solution with the chitosan concentration of 0.02mol/L, adding the calcium chloride acrylate and the polyphosphoric acid in the step (1) into the aqueous solution of chitosan, reacting for 10-20 h at 50-80 ℃, dialyzing and freeze-drying to obtain modified calcium chloride; the weight ratio of the calcium chloride acrylate to the polyphosphoric acid is 1: (8-15).
According to the invention, the antibacterial effect of the liquid oral composition is improved and the stability of the liquid oral composition is maintained by modifying calcium chloride, so that the layering of substances is avoided.
In the invention, the solubility of the modified calcium chloride in water is 0.5g at the temperature of 15-30 ℃.
According to the invention, the acrylic acid AA has high reaction activity, one end of the acrylic acid AA is a strongly acidic carboxyl group and can be bonded with the surface of calcium chloride, the acrylic acid is combined on the surface of calcium chloride with a porous structure, chitosan with a good antibacterial effect is subjected to a grafting reaction with the acrylic acid calcium chloride, and the surface of the obtained modified calcium chloride is covered with polar groups of organic matters containing carboxyl, hydroxyl, amino and the like, so that the modified calcium chloride has surface oleophylic and hydrophilic groups, the stability of the liquid oral composition can be well improved, and the antibacterial effect is also good.
In another aspect of the present invention, there is provided a method for preparing a liquid oral composition containing a Chinese medicinal active substance and tea tree essential oil, comprising the steps of:
(1) adding the traditional Chinese medicine extract, menthol, tea tree essential oil and water according to the weight part, and stirring to dissolve the traditional Chinese medicine extract in the water;
(2) adding additives according to the weight parts, fully stirring, filtering, taking filtrate, and performing sterilization treatment to obtain the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil.
In one embodiment, the sterilization process is instantaneous sterilization using high temperature.
High temperature instantaneous sterilization
The high-temperature instantaneous sterilization refers to a process of rapidly achieving the culture medium temperature of 130-140 ℃ by using saturated steam under a heating condition, maintaining for several minutes, and then rapidly cooling to the culture temperature to complete sterilization. Its advantages are high effect on killing the heat-resistant spores of microbes, less damage to nutrients and high utilization rate of raw materials.
The green tea extract, the affine cudweed extract, the sesamum brachypodium extract, the tea tree root extract, the Chinese gall extract, the honeysuckle extract and the mint extract can clear breath, sterilize and diminish inflammation; the violet extract, the stevia extract, the orange peel extract, the pansy extract and the caraway extract are used for regulating the mouthfeel.
The liquid oral composition containing the traditional Chinese medicine extract has excellent taste, relieves the oral discomfort symptom, keeps good micro-ecology, and has the effects of diminishing inflammation and relieving pain; the invention avoids white lesions of oral mucosa caused by alcohol easily, and avoids the influence of mouth on alcohol test concentration by using the liquid oral composition, and is particularly suitable for oral disinfection after foreign gathering.
The present invention will be specifically described below by way of examples. It should be noted that the following examples are only for illustrating the present invention and should not be construed as limiting the scope of the present invention, and that the insubstantial modifications and adaptations of the present invention by those skilled in the art based on the above disclosure are still within the scope of the present invention.
In addition, the raw materials used are commercially available from national chemical reagents, unless otherwise specified.
Example 1
The preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following steps:
(1) adding the traditional Chinese medicine extract, menthol, tea tree essential oil and water according to the weight part, and stirring to dissolve the traditional Chinese medicine extract in the water;
(2) adding additives according to the weight parts, fully stirring, filtering, taking filtrate, and performing sterilization treatment to obtain the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil.
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 1.6 parts of green tea extract, 0.7 part of affine cudweed extract, 0.5 part of plantain extract, 1.0 part of sesameseed extract, 0.6 part of tea tree root extract, 2.3 parts of gallnut, honeysuckle and orange peel mixed extract, 0.02 part of violet extract, 0.35 part of mint extract, 0.12 part of stevia extract, 0.005 part of pansy extract and 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil and 0.06 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the gallnut to the honeysuckle and the orange peel is 1: 0.3: 0.2; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6.
the preparation method of the modified calcium chloride comprises the following steps:
(1) adding calcium chloride into a high-speed mixer with a charging basket at 50 ℃, adding acrylic acid according to the weight ratio, stirring for 1h, discharging, heating the charging basket of the high-speed mixer to 120 ℃, pouring the materials into the high-speed mixer, stirring at high speed for 1h, and discharging to obtain acrylic acid coated calcium chloride; the weight ratio of the acrylic acid to the calcium chloride is 1: 13;
(2) fully dissolving chitosan in water to prepare an aqueous solution with the chitosan concentration of 0.02mol/L, adding the calcium chloride acrylate and the polyphosphoric acid in the step (1) into the aqueous solution of chitosan, reacting for 18h at 60 ℃, dialyzing and freeze-drying to obtain modified calcium chloride; the weight ratio of the calcium chloride acrylate to the polyphosphoric acid is 1: 10.
example 2
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 2 parts of green tea extract, 0.1 part of affine cudweed extract, 0.1 part of plantain extract, 0.5 part of sesameseed extract, 0.1 part of tea tree root extract, 3 parts of gallnut, honeysuckle and orange peel mixed extract, 0.02 part of violet extract, 1 part of mint extract, 0.12 part of stevia rebaudiana extract, 0.003 part of pansy extract and 0.1 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil, 0.06 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the gallnut to the honeysuckle and the orange peel is 1: 0.3: 0.2; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6.
the preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil and the preparation method of the modified calcium chloride are the same as those in example 1.
Example 3
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 2 parts of green tea extract, 1 part of affine cudweed extract, 1 part of plantain extract, 1.5 parts of sessile sesameseed extract, 0.6 part of tea tree root extract, 0.5 part of Chinese gall, honeysuckle and orange peel mixed extract, 0.05 part of violet extract, 0.1 part of mint extract, 0.12 part of stevia rebaudiana extract, 0.005 part of pansy extract and 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil, 0.06 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the gallnut to the honeysuckle and the orange peel is 1: 0.3: 0.2; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6.
the preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil and the preparation method of the modified calcium chloride are the same as those in example 1.
Example 4
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 1.6 parts of green tea extract, 0.7 part of affine cudweed extract, 0.5 part of plantain extract, 1.0 part of sesameseed extract, 0.6 part of tea tree root extract, 2.3 parts of honeysuckle extract, 0.02 part of violet extract, 0.35 part of mint extract, 0.12 part of stevia rebaudiana extract, 0.003 part of pansy extract and 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil, 0.06 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6.
the extraction method of the honeysuckle extract comprises the following steps:
weighing 20.0g of honeysuckle, drying, crushing, adding ethanol with the mass concentration of 85% -95%, soaking for 2-3 h, extracting for 2-3 times by microwave heating, filtering, and concentrating the filtrate under reduced pressure until no ethanol exists, thus obtaining the honeysuckle tea.
The preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil and the preparation method of the modified calcium chloride are the same as those in example 1.
Example 5
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 1.6 parts of green tea extract, 0.7 part of affine cudweed extract, 0.5 part of plantain extract, 1.0 part of sesameseed extract, 0.6 part of tea tree root extract, 2.3 parts of Chinese gall extract, 0.02 part of violet extract, 0.35 part of mint extract, 0.12 part of stevia rebaudiana extract, 0.003 part of pansy extract and 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil, 0.06 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6.
the extraction method of the Chinese gall extract comprises the following steps:
weighing 20.0g of gallnut, cleaning, drying, crushing, adding ethanol with the mass concentration of 70-85%, soaking for 2-3 h, extracting for 2-3 times by microwave heating, filtering, and concentrating the filtrate under reduced pressure until no ethanol exists, thus obtaining the Chinese gall tea.
The preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil and the preparation method of the modified calcium chloride are the same as those in example 1.
Example 6
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 1.6 parts of green tea extract, 0.7 part of affine cudweed extract, 0.5 part of plantain extract, 1.0 part of sesameseed extract, 0.6 part of tea tree root extract, 2.3 parts of orange peel extract, 0.02 part of violet extract, 0.35 part of mint extract, 0.12 part of stevia rebaudiana extract, 0.003 part of pansy extract and 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil, 0.06 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6.
the extraction method of the orange peel extract comprises the following steps:
weighing 20.0g of orange peel, drying, crushing, adding 50-60% ethanol, soaking for 2-3 h, extracting for 2-3 times by microwave heating, filtering, and concentrating the filtrate under reduced pressure until no ethanol exists, thus obtaining the orange peel tea.
The preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil and the preparation method of the modified calcium chloride are the same as those in example 1.
Example 7
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 0.7 part of affine cudweed extract, 0.5 part of plantain herb extract, 1.0 part of sesameseed extract, 2.3 parts of gallnut, honeysuckle and orange peel mixed extract, 0.02 part of violet extract, 0.35 part of mint extract, 0.12 part of stevia extract, 0.003 part of pansy extract, 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid, 0.05 part of propolis, 0.003 part of lemon oil and 0.06 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the gallnut to the honeysuckle and the orange peel is 1: 0.3: 0.2.
the preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil and the preparation method of the modified calcium chloride are the same as those in example 1.
Example 8
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 1.6 parts of green tea extract, 0.7 part of affine cudweed extract, 0.5 part of plantain extract, 1.0 part of sesameseed extract, 0.6 part of tea tree root extract, 2.3 parts of gallnut, honeysuckle and orange peel mixed extract, 0.02 part of violet extract, 0.35 part of mint extract, 0.12 part of stevia extract, 0.005 part of pansy extract and 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil and 0.01 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the gallnut to the honeysuckle and the orange peel is 1: 0.3: 0.2; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6.
the preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil and the preparation method of the modified calcium chloride are the same as those in example 1.
Example 9
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 1.6 parts of green tea extract, 0.7 part of affine cudweed extract, 0.5 part of plantain extract, 1.0 part of sesameseed extract, 0.6 part of tea tree root extract, 2.3 parts of gallnut, honeysuckle and orange peel mixed extract, 0.02 part of violet extract, 0.35 part of mint extract, 0.12 part of stevia extract, 0.005 part of pansy extract and 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil and 0.15 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the gallnut to the honeysuckle and the orange peel is 1: 0.3: 0.2; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6.
the preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil and the preparation method of the modified calcium chloride are the same as those in example 1.
Comparative example 1
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 1.6 parts of green tea extract, 0.7 part of affine cudweed extract, 0.5 part of plantain extract, 1.0 part of sesameseed extract, 0.6 part of tea tree root extract, 2.3 parts of gallnut, honeysuckle and orange peel mixed extract, 0.02 part of violet extract, 0.35 part of mint extract, 0.12 part of stevia extract, 0.005 part of pansy extract and 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil and 0.06 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the gallnut to the honeysuckle and the orange peel is 1: 0.3: 0.2; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6; the modified calcium chloride is acrylic acid coated calcium chloride.
The preparation method of the modified calcium chloride comprises the following steps:
adding calcium chloride into a high-speed mixer with a charging basket at 50 ℃, adding acrylic acid according to the weight ratio, stirring for 1h, discharging, heating the charging basket of the high-speed mixer to 120 ℃, pouring the materials into the high-speed mixer, stirring at high speed for 1h, and discharging to obtain acrylic acid coated calcium chloride; the weight ratio of the acrylic acid to the calcium chloride is 1: 13.
the preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil is the same as that of example 1.
Comparative example 2
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 1.6 parts of green tea extract, 0.7 part of affine cudweed extract, 0.5 part of plantain extract, 1.0 part of sesameseed extract, 0.6 part of tea tree root extract, 2.3 parts of gallnut, honeysuckle and orange peel mixed extract, 0.02 part of violet extract, 0.35 part of mint extract, 0.12 part of stevia extract, 0.005 part of pansy extract and 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil, 0.06 part of calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the gallnut to the honeysuckle and the orange peel is 1: 0.3: 0.2; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6.
the preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil is the same as that of example 1.
Comparative example 3
The liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil comprises the following components in parts by weight: 0.5 part of plantain extract, 2.3 parts of orange peel extract, 0.02 part of violet extract, 0.12 part of stevia rebaudiana extract, 0.005 part of pansy extract and 0.007 part of caraway extract, 3.1 parts of xylitol, 0.15 part of citric acid and sodium citrate, 0.05 part of propolis, 0.003 part of limonene and lemon oil and 0.06 part of modified calcium chloride, 0.002 part of menthol, 0.003 part of tea tree essential oil and 92 parts of water; the weight ratio of the citric acid to the sodium citrate is 1: 0.8; the weight ratio of the limonene to the lemon oil is 1: 0.6.
the preparation method of the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil and the preparation method of the modified calcium chloride are the same as those in example 1.
And (3) performance testing:
1. evaluation of appearance stability:
450ml of the sample liquid oral composition was filled in a PET container filled with 450ml of the full scale, and the stability after 3 months of storage in a thermostatic bath at 50 ℃ or 3 months of storage in a thermostatic bath at-10 ℃ was visually judged. Evaluation criteria for appearance stability (50 ℃ C., 3 months):
well: the color tone of the formulation did not change;
in general: the shade of the formulation faded only slightly but not at a problematic level;
difference: the color tone of the formulation was discolored.
Evaluation criteria for appearance stability (-10 ℃, 3 months):
well: no change;
in general: very little separation can be seen, but at an unproblematic level;
difference: there was separation and fading of the color tone of the preparation.
2. Taste of the product
After rinsing 10ml of a sample (liquid oral composition) for 30 seconds, subjects evaluated the continuation of cooling sensation, the feeling of retained reality, and the feeling of no retained viscosity after rinsing 10 minutes with the preparation, and evaluated the average score of 10 subjects according to the following criteria.
(1) Persistence of cooling sensation
And 5, dividing: persistence of a cool feeling is strongly felt
And 4, dividing: the persistence of the refreshing feeling was strongly felt
And 3, dividing: feeling of persistence of a refreshing feeling
And 2, dividing: persistence of substantially no cooling sensation
1 minute: the persistence of a cooling sensation is not felt;
(2) sense of retention
And 4, dividing: the feeling of remaining mouthwash in the mouth was strongly felt
And 3, dividing: feeling of remaining of mouthwash in mouth
And 2, dividing: substantially no feeling of remaining mouthwash in the mouth
1 minute: the residual sense of the mouthwash in the mouth is not felt;
(3) viscous feeling
And 4, dividing: no sticky feeling
And 3, dividing: basically no sticky feeling is felt
And 2, dividing: feeling of stickiness
1 minute: a sticky feeling is strongly felt.
3. Bacteriostatic activity
In a sterile table, 9ml of each of the liquid oral compositions of examples and comparative examples and physiological saline as a control were added to a sterile glass test tube. Then, 1ml of Escherichia coli bacterial liquid (photometric value (O.D) 0.1, colony count 106CFU/ml) was added to each sterile glass tube and mixed, and then densitometric measurement was performed. And simultaneously taking out the bacterial liquid from each sterile glass test tube, and smearing the diluted bacterial liquid in a solid culture medium for measurement by a coating method. Then each sterile glass test tube and each solid culture medium are placed in a constant temperature incubator at 37 ℃ for culture for 8 hours, and then the light absorption value of each sterile glass test tube after culture and the colony number of each coating plate after culture are measured.
The bacteriostatic activity of the coating method is that the difference between the number of the colonies cultured by the coating of the control group and the number of the colonies cultured by the coating of the experimental group is divided by the number of the colonies cultured by the coating of the control group. And respectively testing escherichia coli, staphylococcus aureus and pseudomonas aeruginosa to obtain the data of the antibacterial activity.
Table 1 results of performance testing
As can be seen from the above test results, the present invention has not only excellent taste, alleviation of oral discomfort symptoms, maintenance of good micro-ecology, but also anti-inflammatory and analgesic effects, as compared with comparative examples of acrylic acid-coated calcium chloride, no green tea extract, gnaphalium affine extract, brevifolium extract, camellia sinensis root extract, gallnut extract, honeysuckle extract, mint extract.
The foregoing examples are merely illustrative and serve to explain some of the features of the method of the present invention. The appended claims are intended to claim as broad a scope as is contemplated, and the examples presented herein are merely illustrative of selected implementations in accordance with all possible combinations of examples. Accordingly, it is applicants' intention that the appended claims are not to be limited by the choice of examples illustrating features of the invention. Also, where numerical ranges are used in the claims, subranges therein are included, and variations in these ranges are also to be construed as possible being covered by the appended claims.
Claims (6)
1. A liquid oral composition containing traditional Chinese medicine active substances and tea tree essential oil is characterized by comprising the following components in parts by weight:
wherein the Chinese medicinal extract comprises green tea extract, herba Gnaphalii affinis extract, herba plantaginis extract, herba Lamii Barbati extract, tea tree root extract, Galla chinensis, flos Lonicerae and pericarpium Citri Junoris mixed extract, and violet extract; the additives comprise wetting agents, pH regulators, preservatives, essences and flocculants;
the Chinese medicinal extract also comprises herba Menthae extract, sweet stevia extract, herba Violae Hortensis extract, and fructus Cari Carvi extract;
the traditional Chinese medicine extract comprises, by weight, 1-2 parts of a green tea extract, 0.1-1 part of a affine cudweed extract, 0.1-1 part of a plantain extract, 0.5-1.5 parts of a sessile sesameseed extract, 0.1-1.0 part of a tea tree root extract, 0.5-3 parts of a mixed extract of gallnut, honeysuckle and orange peel, 0.01-0.1 part of a violet extract, 0.1-1.2 parts of a mint extract, 0.05-1.0 part of a stevia rebaudiana extract, 0.003-0.2 part of a pansy extract and 0.005-0.3 part of a caraway extract;
the flocculant is modified calcium chloride, and the modified calcium chloride is chitosan grafted after calcium chloride is coated by acrylic acid; the grafting rate of the modified calcium chloride is 1-5%;
the preparation method of the modified calcium chloride comprises the following steps:
(1) adding calcium chloride into a high-speed mixer with a charging basket at 50 ℃, adding acrylic acid according to the weight ratio, stirring for 0.5-2 h, discharging, raising the temperature of the charging basket of the high-speed mixer to 120 ℃, pouring the materials into the high-speed mixer, stirring at high speed for 0.5-1 h, and discharging to obtain acrylic acid coated calcium chloride; the weight ratio of the acrylic acid to the calcium chloride is 1: 10-20;
(2) fully dissolving chitosan in water to prepare an aqueous solution with the chitosan concentration of 0.02mol/L, adding the calcium chloride acrylate and the polyphosphoric acid in the step (1) into the aqueous solution of chitosan, reacting for 10-20 h at 50-80 ℃, dialyzing and freeze-drying to obtain modified calcium chloride; the weight ratio of the calcium chloride acrylate to the polyphosphoric acid is 1: 8-15;
the pH regulator is citric acid and sodium citrate.
2. The liquid oral composition according to claim 1, comprising a combination of herbal actives and tea tree essential oil,
the wetting agent comprises one or more of sorbitol, xylitol, maltitol, lactitol and ethylene glycol.
3. The liquid oral composition comprising herbal actives and tea tree essential oil as claimed in claim 1, wherein the preservative comprises one or more of sodium benzoate, methylparaben, ethylparaben, propylparaben, butylparaben, glycine alkyl diamino ethyl ester hydrochloride, potassium sorbate, propolis.
4. The liquid oral composition as claimed in claim 1, wherein the essence comprises one or more of spearmint oil, eucalyptus oil, wintergreen oil, clove oil, thyme oil, sage oil, cardamom oil, rosemary oil, marjoram oil, lemon oil, nutmeg oil, lavender oil, geranium oil, L-carvone, 1, 8-cineole, methyl salicylate, eugenol, thymol, linalool, limonene, menthone, menthyl acetate, citral, camphor, borneol, pinene, spilanthol.
5. The liquid oral composition containing a herbal active ingredient and tea tree essential oil according to claim 1, wherein the modified calcium chloride has a grafting ratio of 1 to 3%.
6. The method for preparing the liquid oral composition comprising the Chinese medicinal active substance and the tea tree essential oil according to any one of claims 1 to 5, comprising the steps of:
(1) adding the traditional Chinese medicine extract, menthol, tea tree essential oil and water according to the weight part, and stirring to dissolve the traditional Chinese medicine extract in the water;
(2) adding additives according to the weight parts, fully stirring, filtering, taking filtrate, and performing sterilization treatment to obtain the liquid oral composition containing the traditional Chinese medicine active substances and the tea tree essential oil.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610943361.9A CN106562921B (en) | 2016-11-02 | 2016-11-02 | A liquid oral composition containing Chinese medicinal active substances and tea tree essential oil |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610943361.9A CN106562921B (en) | 2016-11-02 | 2016-11-02 | A liquid oral composition containing Chinese medicinal active substances and tea tree essential oil |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106562921A CN106562921A (en) | 2017-04-19 |
CN106562921B true CN106562921B (en) | 2020-11-24 |
Family
ID=58536386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610943361.9A Expired - Fee Related CN106562921B (en) | 2016-11-02 | 2016-11-02 | A liquid oral composition containing Chinese medicinal active substances and tea tree essential oil |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106562921B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10933096B2 (en) * | 2017-12-22 | 2021-03-02 | Aesthetics Biomedical, Inc. | Biologic preserving composition and methods of use |
WO2019126557A1 (en) * | 2017-12-22 | 2019-06-27 | Aesthetics Biomedical, Inc. | Biologic preserving composition and methods of use |
CN108272675A (en) * | 2018-03-18 | 2018-07-13 | 太极娃生物科技有限公司 | Pediatric Oral Emergency care composition and its application in children's anti-caries |
CN108852939A (en) * | 2018-08-23 | 2018-11-23 | 无限极(中国)有限公司 | A kind of moisture-keeping composition and its cosmetics of preparation |
CN115770205A (en) * | 2021-09-04 | 2023-03-10 | 武汉左点科技有限公司 | Oral cavity cleaning liquid and preparation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101007077B (en) * | 2006-01-25 | 2011-10-26 | 杭州北斗生物技术有限公司 | Composite for oral cavity containing natural plant extracts |
CN101642420B (en) * | 2009-06-18 | 2011-05-25 | 杭州六易科技有限公司 | Method for preparing refreshing agent for oral cavity |
CN104887581B (en) * | 2015-06-11 | 2018-02-23 | 云南天美天康生物科技有限公司 | A kind of oral care composition and preparation method thereof |
-
2016
- 2016-11-02 CN CN201610943361.9A patent/CN106562921B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN106562921A (en) | 2017-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106562921B (en) | A liquid oral composition containing Chinese medicinal active substances and tea tree essential oil | |
CN108785161B (en) | Antibacterial mouth wash containing licoflavone and preparation method thereof | |
CN103860423B (en) | A kind of have collutory of anti-inflammation deodorize and its production and use | |
CN111202822A (en) | Gynecological external antibacterial spray and preparation method thereof | |
CN1947697B (en) | Herbal true aqueous solution type oral cavity cleaning agent and its preparation method | |
CN110840768B (en) | Artemisia argyi essence stock solution and preparation method thereof | |
CN111265560A (en) | Gynecological lotion and preparation method thereof | |
Singh et al. | The portent plant with a purpose: Aloe vera | |
CN101181208B (en) | Gargle containing natural antibiotics and preparation method thereof | |
CN107320758B (en) | Air purifying agent for efficiently removing bacteria in livestock and poultry breeding environment | |
CN111714674B (en) | Traditional Chinese medicine volatile oil and preparation method and application thereof | |
CN112791030A (en) | Mouthwash and preparation method thereof | |
CN107913234B (en) | Pilose antler grass toothpaste and preparation method thereof | |
KR100903827B1 (en) | The hand-made traditional oriental soap and the manufacture method | |
CN111053937A (en) | Plant-extracted household deodorizing and deodorizing disinfection composition and preparation method thereof | |
CN109248258A (en) | Nursing Chinese herbal medicine gargle after a kind of operation on oral cavity | |
CN109464540A (en) | A kind of alleviation oral cavity and the spray of throat discomfort and preparation method thereof | |
CN111012703A (en) | Pure natural pH balance care solution and preparation method thereof | |
CN110652465A (en) | Plant polypeptide nursing composition | |
CN111743835A (en) | Composition of mucosa repair antibacterial liquid and application | |
KR20170043057A (en) | Composition for wet tissue | |
KR102691500B1 (en) | Leaf up gum care toothpaste | |
KR102603744B1 (en) | A cosmetic composition for aromatherapy comprising of Yuza citron extract and aroma complex hydrosol and preparation method thereof | |
CN116831966A (en) | Chinese herbal medicine type nursing mouthwash for old people and preparation method and application thereof | |
AU2021101182A4 (en) | A formula of pure natural plant antimicrobial health care wipes and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20201124 |
|
CF01 | Termination of patent right due to non-payment of annual fee |